SCHEMBL766700

SCHEMBL766700

CCOC(=O)c1noc(-c2ccc(C(F)(F)F)c(F)c2)c1CBr

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 5/20 0.54
MLYCD O95822 1/20 0.43
CYP11B1 P15538 3/20 0.42
CYP11B2 P19099 3/20 0.42
ALDH1A1 P00352 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KIF11 P52732 1/20 0.39
USP2 O75604 1/20 0.38
POLB P06746 1/20 0.38
P2RX7 Q99572 1/20 0.38
TARBP2 Q15633 1/20 0.38
HTT P42858 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
PPARD Q03181 1/20 0.36
TDP2 O95551 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13257566 0.90 TRPV1 (0.54) TRPV1MLYCDCYP11B1CYP11B2ALDH1A1
SCHEMBL766496 0.87 TRPV1 (0.55) TRPV1MLYCDCYP11B1CYP11B2ALDH1A1
SCHEMBL766505 0.84 MLYCD (0.52) TRPV1MLYCD
SCHEMBL768606 0.80 TARBP2 (0.50) MLYCDALDH1A1POLBTARBP2HTT
SCHEMBL1686298 0.76 NOTUM (0.55) CYP11B1CYP11B2ALDH1A1L3MBTL1KIF11
SCHEMBL766679 0.74 TRPV1 (0.69) TRPV1KIF11P2RX7
SCHEMBL1686549 0.74 TRPV1 (0.59) TRPV1CYP11B1CYP11B2KIF11P2RX7
SCHEMBL766613 0.73 TRPV1 (0.56) TRPV1CYP11B1CYP11B2KIF11P2RX7
SCHEMBL766813 0.73 TRPV1 (0.62) TRPV1MLYCD
SCHEMBL1686447 0.73 TRPV1 (0.61) TRPV1CYP11B1CYP11B2KIF11P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120071481-A1 ISOXAZOLE-5-CARBOXAMIDE DERIVATIVES MERCK SHARP & DOHME B.V. (NL) 2012-03-22 US disclosed
US-20120071481-A1 ISOXAZOLE-5-CARBOXAMIDE DERIVATIVES MERCK SHARP & DOHME B.V. (NL) 2012-03-22 US disclosed
US-20120071481-A1 ISOXAZOLE-5-CARBOXAMIDE DERIVATIVES MERCK SHARP & DOHME B.V. (NL) 2012-03-22 US disclosed
EP-2393789-A1 ISOXAZOLE-3-CARBOXAMIDE DERIVATIVES N.V. Organon (NL) 2011-12-14 EP disclosed
WO-2010091009-A1 ISOXAZOLE-3-CARBOXAMIDE DERIVATIVES N.V. ORGANON (NL) 2010-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071481-A1 ISOXAZOLE-5-CARBOXAMIDE DERIVATIVES TRPV1, TRPV5, TRPV3 TRPV1 1/4885MLYCD 2174/4885CYP11B1 2034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.